will defend it (Updates with BioNTech statement) By Patricia Weiss BERLIN, July 5 (Reuters) - CureVac has filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology ...

COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S.

German biotech company CureVac said Tuesday it has filed a patent infringement lawsuit against rival BioNTech for work that it says contributed to the development of the BioNTech-Pfizer ...

In January, CureVac began discussions with BioNTech and Pfizer over intellectual property rights. Attempts to resolve differences were unsuccessful, and CureVac filed a lawsuit against BioNTech in the ...

CureVac, filed a lawsuit earlier this month against BioNTech, making the claim that CureVac should be compensated for an apparent infringement of a range of patents. The suit took place in German ...

COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the US District Court in Massachusetts, seeking a judgment that they did not infringe US ...

The lawsuit https://tmsnrt.rs/3PAjBo7, filed Monday, said CureVac is trying to profit from the success of BioNTech and Pfizer’s COVID-19 vaccines after CureVac’s efforts to create its own ...

The lawsuit, filed Monday, said CureVac is trying to profit from the success of BioNTech and Pfizer's COVID-19 vaccines after CureVac's efforts to create its own vaccine failed. CureVac earlier ...